Noxopharm Limited
NOXOF · OTC
6/30/2024 | 6/30/2023 | 6/30/2022 | 6/30/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$3,578 | -$15,056 | -$18,667 | -$9,347 |
| Dep. & Amort. | $0 | $155 | $262 | $262 |
| Deferred Tax | $0 | -$12 | -$804 | -$1,742 |
| Stock-Based Comp. | $0 | $12 | $804 | $1,742 |
| Change in WC | $3,735 | -$591 | -$5,071 | $3,602 |
| Other Non-Cash | -$841 | $4,546 | $9,743 | -$3,367 |
| Operating Cash Flow | -$684 | -$10,946 | -$13,734 | -$8,850 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | $0 | $0 | $0 | $0 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | $0 | $0 | $0 | $0 |
| Inv. Sales/Matur. | $0 | $124 | $0 | $0 |
| Other Inv. Act. | $0 | $124 | $0 | $225 |
| Investing Cash Flow | $0 | $124 | $0 | $225 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $2,000 | $0 | $0 | $0 |
| Stock Issued | $0 | $0 | $1,205 | $28,569 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | -$2,000 | -$178 | -$229 | -$245 |
| Financing Cash Flow | $0 | -$178 | $976 | $28,324 |
| Forex Effect | -$4 | -$1 | -$27 | -$4 |
| Net Chg. in Cash | -$689 | -$11,002 | -$12,785 | $19,696 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $3,009 | $14,011 | $26,796 | $7,100 |
| End Cash | $2,320 | $3,009 | $14,011 | $26,796 |
| Free Cash Flow | -$684 | -$10,946 | -$13,734 | -$8,850 |